In the U.S., the two hottest locations for biotech startups are Cambridge, Massachusetts and the San Francisco Bay Area. Generally speaking, the reason is proximity to major research institutions and universities, and interested venture capital. But at least in the case of the Boston area, the growth hasn’t just been a happy conjunction of academia and venture firms. Developer Alexandria Real Estate Equities has worked to make it happen.
